APACC 2022
Day 1 - Thursday, 16 June 2022
Day 2 - Friday, 17 June 2022
Day 3 - Saturday, 18 June 2022
** Industry-supported Symposia programs can be visited in "Symposia" Tab.
Thursday, 16 June 2022
Friday, 17 June 2022
What's New
- Registrations for APACC 2023 will soon open.
- To stay updated on developments about APACC 2023, make sure you sign up for our newsletter.
Welcome Message
Dear colleagues,
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2022 will be held from 16 to 18 June 2022 as a virtual program.
Over the years, enormous progress has been made in the fight against HIV and co-infections with HIV. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat their HIV and co-infected patients. However, international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, most major conferences do not usually address local and regional issues. In particular, the Asian medical community in this field of research currently has very few platforms that serve the needs of HIV healthcare professionals in this region.
APACC provides a much-needed scientific platform that focuses on the developments, issues, and needs in the Asia-Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking, and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round table discussions, and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.
We look forward to meeting you virtually at APACC 2022!
Nittaya Phanuphak, Reena Rajasuriar, and Joseph Tucker.
Co-chairs, APACC 2022
We are available to answer any questions or concerns that you may have about your participation at APACC 2022. For more information, please contact us via yeening.tham@amededu.com.
Practical Information
-
Registration for APACC 2022 is closed.
-
Registration for APACC 2023 is now open. Click here to register.
APACC 2022 is accredited by the following societies. To claim the CME points, members of the societies must log on to the virtual congress portal and attend the full sessions. Additional information such as membership number or license number might be required after the event.
Hong Kong Academy of Medicine (HKAM)
APACC 2022 is accredited by the Hong Kong Academy of Medicine (HKAM) up to 12 credits. To claim the CME points, members of the HKAM must log on to the virtual congress portal and attend the full sessions.
|
College |
16 June |
17 June |
18 June |
|
Physicians |
3.5 CME Points |
4.5 CME Points |
3.5 CME Points |
Infectious Diseases Association of Thailand (IDAT)
APACC 2022 is accredited by the Infectious Diseases Association of Thailand (IDAT) up to 14.5 credits. To claim the CME points, members of the IDAT must log on to the virtual congress portal and attend the full sessions.
|
16 June |
17 June |
18 June |
|
4.75 CME Points |
4.75 CME Points |
5 CME Points |
European Accreditation Council for Continuing Medical Education (EACCME®)
The Asia-Pacific AIDS & Co-Infections Conference (APACC) 2022, Virtual, Netherlands, 16/06/2022-18/06/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 11 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.
Taiwan AIDS society
APACC 2022 is accredited by the Taiwan AIDS Society with 4 credits. To claim the CME points, members of the Taiwan AIDS Society must log on to the virtual congress portal and attend the full sessions.
Chairs 2022
Organizing Committee
Thuy Le, MD, DPhil
The members of the Organizing Committee are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the workshop, identify interesting topics and candidate speakers, and review all submitted abstracts.
Scientific Committee
Chien-Ching Hung, MD, PhD
Nagalingeswaran Kumarasamy, MD, FRCP, PhD
The members of Scientific Committee are hand-picked by the Organizing Committee and the conference secretariat based on their significant contributions and commitment to the field. They assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.
APACC Fellows (2021-2022)
Kasha Priya Singh, MBBS, MPH, FRACP
Rayner Kay Jin Tan, PhD
The purpose of the APACC Fellows Program is to provide early-career investigators with an opportunity to learn about HIV and co-infection research, conference organization, and leadership through serving on the Organizing Committee of APACC. Fellows will help to develop conference session content for other early-career investigators and promote APACC over a two-year term. The Organizing Committee is responsible for the overall content of the conference program, driving conference engagement, and selecting abstracts and panel topics. Fellows will receive support to attend the conference for each of the two years in which they participate (remotely or in-person, as appropriate).
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals and community representatives involved in HIV and co-infections with HIV.
This collaboration plays a vital role in both the organizational as well as the scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Rikke Puggaard-Rode at Rikke.Rode@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company. *Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Digital and printed advertising opportunities
- Social media shout-outs
*Subject to the support level.
APACC 2022 is endorsed by the following societies and organizations. Their support and collaboration are key to the success of this program!
If you would like your organization to endorse this meeting, please contact Rikke Rode at Rikke.Rode@amededu.com
We are delighted to announce that APACC 2022 will have two local hubs!
One in Guangzhou City, China, for around 20 delegates. This hub is supported by SESH - Social Entrepreneurship to Spur Health.
Another in Bangkok, Thailand, for around 40 delegates. This hub is supported by IHRI - Institute of HIV Research and Innovation.
Should you and your organization wish to organize a local hub for APACC 2022, please do not hesitate to reach out.
Abstract submission is closed for APACC 2022.
APACC provides a platform for the investigators in the Asia-Pacific region to present their latest research or share their experiences in the field of HIV and co-infections with HIV!
We welcome two types of abstracts:
- Research abstracts: Present the latest results from your study or research and discuss the findings with an expert audience.
- “Lessons learned” abstracts: What worked and what did not work? Share your experiences and exchange ideas with a multidisciplinary audience.
"Research abstracts" have to be submitted in a structured format (Background, Materials and Methods, Results, Conclusions), and "Lessons learned abstracts" can be submitted in a descriptive (non-structured) format.
APACC accepts encore abstracts and industry-submitted abstracts as long as the research is focused on the Asia-Pacific and has new data at the time of the conference.
Co-submission of abstracts with AIDS 2022 is allowed. Both media representatives, as well as abstract submitters to submit abstracts to both APACC 2022 and AIDS 2022, are required to comply with the AIDS 2022 embargo policy.
Once the submission is open, authors can submit their abstracts electronically until 1 April, at 23.59 GMT+7. Please follow the step-by-step directions to upload the abstract. To ensure your abstract does not contain any special characters or formatting, the abstract must be in Microsoft Word format.
General Guidelines
"Research abstracts" should contain the following four components:
- Background: A concise statement of the issue under investigation or a hypothesis;
- Material and Methods: The experimental methods used (including the statistical analyses employed);
- Results: Specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
- Conclusions: A summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).
"Lessons learned abstracts" can be submitted in a descriptive (non-structured) format.
Please note that abstracts cannot be accepted if tables or graphs are included. The maximum word count for the abstract body is 500 words.
Abstracts are considered official communications to the conference and will be treated confidentially. Submitters of accepted abstracts agree to attend the meeting and present their abstract as scheduled.
Terms and Conditions
By submitting an abstract to a meeting organized by Virology Education BV (VE) or Academic Medical Education BV (AME), the abstract submitter hereby agrees to the terms and conditions.
The terms and conditions can be viewed here.
BASIC SCIENCE
- Basic Immunology and Vaccine Development (HIV, SARS-CoV2, and Others)
- Immune Responses to SARS-CoV2 Infection and Vaccination
- HIV Virology
- Latency and Viral Reservoirs
- Novel Treatment and Cure Strategies
CLINICAL SCIENCE
- Antiretroviral Drug Resistance
- Antiretroviral Therapies in Adults (Clinical Trials and Observational Cohort Studies)
- Co-Morbidities and Complications (STI and Non-Communicable Disease)
- Testing, Treatment, and Prevention of COVID-19 in PLWH and Understudied Populations
- Sexually Transmitted Infections in PLWH and Understudied Populations
- Diagnostic and Monitoring Tools
- HIV Infection and Treatment in Understudied Populations (Children, Adolescents, Women, Elderly, etc.)
- Health Outcomes in Older PLWH
- Linkage and Retention in Care
- Non-ART Strategies and Therapies
- Pharmacology of ARVs
PREVENTION SCIENCE
- Approaches for HIV Prevention
- Epidemiology and Surveillance of HIV / STIs / Hepatitis
- Feasibility and Impact of Structural Interventions
- Population-Specific Interventions and Prevention Strategies
- Prevention of Mother-to-Child Transmission
- Tools for HIV Prevention
- Behavioral HIV/STI/Hepatitis Research
IMPLEMENTATION SCIENCE
- Infrastructure and Delivery Models for the Scale-Up of Services
- Stigma
CO-INFECTIONS INCLUDING VIRAL HEPATITIS
- Diagnostics and Treatment of Co-Infections
- Epidemiology and Surveillance of Co-infections
- HBV Therapeutics and Approaches in the Co-infection Section
- HCV Therapeutics and Approaches
- Novel TB Treatment Strategies
IMPORTANT: the registration fee waiver is offered to the presenting author of the abstract only.
Applicants should:
- Be a current Master/ PharmD/ PhD student; OR
- Have obtained an MD/ PharmD/ PhD degree in the last five years.
An application form (available below) needs to be completed by a supervisor and received by the Virology Education at least 2 weeks before the start of the conference.
Virology Education will contact the young investigator with instructions regarding registration for the workshop once the application has been received.
VE and AME is the sole copyright holder of the conference abstract book as a whole (also referred to as the Reviews in Antiviral Therapy & Infectious Diseases). The abstract authors will retain any and all copyright over their individual abstract. Information on copyright can be viewed in the abstract submission terms and conditions (see 'Terms and Conditions' above).
Scholarship application is closed for APACC 2022!
The scholarship application is closed for APACC 2022. The deadline was 15 May 2022.
If you have financial concerns, don't hesitate to get in touch with the conference secretariat at yeening.tham@amededu.com.
Who Can Apply?
APACC 2022 welcomes registration scholarship applications from the following groups:
- Academia from Resource-Limited Settings;
- Clinical Virologists;
- Community Health Workers / Community Lay Providers;
- Early-Career Professionals Including Those Undergoing Training;
- Government Representatives;
- NGO/CSO/Community Representatives including Advocates;
- People Living with HIV;
- Pharmacists;
- Pharmacologists;
- Practicing Clinicians / Prescribers; and
- Early-Career Investigators including post-graduate students.
The applicant will be asked to submit a motivational letter (max. 200 words) describing how their patients/research/community will benefit from the knowledge gained at this conference (mandatory). In addition, early-career investigators will be asked to submit a Early-Career Investigator form.
See downloadable forms below.
- All applications will be acknowledged upon receipt.
- All applicants will be notified about the status of their application no later than 20 May 2022.
- Successful applicants will be sent a discount code for complimentary registration.
- Be proficient enough in English to interact with faculty and fellow attendees;
- Be actively involved in the field of HIV and/or co-infections with HIV (such as hepatitis);
- Be able to show benefits to their patients / research / community from attending the conference; and
- Be willing to share information learned at the conference with a larger community.
The organizer will automatically decline all scholarship applications that do not conform to the eligibility terms.
• The applicant will provide the completed post-meeting feedback to the organizer.
• The applicant must confirm that they will be responsible for all other costs associated with conference attendance such as internet usage and use of a computer device.
• The applicant will not hold the organizer liable for any losses, costs, expenses, causes of action, claims, and suits for property damage, theft of property, or personal injury (including death) arising in connection with the Scholarship and participation in the conference.
• The applicant agrees to be responsible for taking out their relevant own insurance policies.
• The Scholarship is non-transferable.
• Incomplete Scholarship applications will not be considered.
• Retrospective Scholarship applications will not be considered.
• Organizer cannot be held responsible for any incorrect information that is submitted via email or through the Scholarship application portal.
• Scholarship applications will be considered until the exhaustion of funds.
• The Scholarship applicants will be notified of the decision by email. Successful applicants will be notified with further instructions.
• Organizer reserves the right to make the final decision regarding all Scholarship applications, which cannot be disputed.
Top-Rated Materials from Previous Editions
Virology of SARS-Cov-2 - Linfa Wang, PhD, FTSE
APACC 2021
